131 related articles for article (PubMed ID: 32985559)
1. Effects of HIV-1 genotype on baseline CD4+ cell count and mortality before and after antiretroviral therapy.
Cao Z; Li J; Chen H; Song C; Shen Z; Zhou X; Lan G; Zhu Q; Liang S; Xing H; Liao L; Feng Y; Shao Y; Ruan Y
Sci Rep; 2020 Sep; 10(1):15875. PubMed ID: 32985559
[TBL] [Abstract][Full Text] [Related]
2. After 18 months of antiretroviral therapy, total HIV DNA decreases more pronouncedly in patients infected by CRF01_AE than in those infected by subtype B and CRF07_BC.
Lu Z; Jiao Y; Li J; Lan G; Lu C; Li X; Tang Z; Wang N
Microbiol Immunol; 2018 Apr; 62(4):248-254. PubMed ID: 29377267
[TBL] [Abstract][Full Text] [Related]
3. Impacts of HIV-1 Subtype Diversity on Long-Term Clinical Outcomes in Antiretroviral Therapy in Guangxi, China.
Jiang H; Lan G; Zhu Q; Feng Y; Liang S; Li J; Zhou X; Lin M; Shao Y
J Acquir Immune Defic Syndr; 2022 Apr; 89(5):583-591. PubMed ID: 34966146
[TBL] [Abstract][Full Text] [Related]
4. Increased rate of CD4+ T-cell decline and faster time to antiretroviral therapy in HIV-1 subtype CRF01_AE infected seroconverters in Singapore.
Ng OT; Lin L; Laeyendecker O; Quinn TC; Sun YJ; Lee CC; Leo YS
PLoS One; 2011 Jan; 6(1):e15738. PubMed ID: 21298051
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of transmitted HIV-1 drug resistance remains low in Guangxi, China, eight years after scale-up of highly-active antiretroviral therapy.
Li G; Liang S; Harrison TJ; Tang Z; Shen Z; Wang X; Wu X; Liu W; Liang F; Feng L; Yang J; Fang Z
Intervirology; 2014; 57(5):270-6. PubMed ID: 24994115
[TBL] [Abstract][Full Text] [Related]
6. Genotypes and transmitted drug resistance among treatment-naive HIV-1-infected patients in a northwestern province, China: trends from 2003 to 2013.
Zhao K; Kang W; Liu Q; Li Y; Liu Q; Jiang W; Zhuang Y; Guo Z; Yu Z; Li X; Wang C; Yao N; Sun Y
PLoS One; 2014; 9(10):e109821. PubMed ID: 25333965
[TBL] [Abstract][Full Text] [Related]
7. [HIV genetic subtypes and comparison of the first CD(4)(+)T cell counts in newly diagnosed HIV infected patients in Liuzhou, 1998-2012].
Cao ZQ; Yang WM; Zhu QY; Lan GH; Shen ZY; Liang SS; Li JJ; Chen HH; Feng Y; He X; Liao LJ; Xing H; Ruan YH; Shao YM
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 May; 40(5):580-584. PubMed ID: 31177742
[No Abstract] [Full Text] [Related]
8. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 genotype is independently associated with immunodeficiency progression among Chinese men who have sex with men: an observational cohort study.
Liang Y; Han Z; Shui J; Cheng W; Zhong F; Cai Q; Wang H; Wu H; Xu H; Tang S
HIV Med; 2020 May; 21(5):279-288. PubMed ID: 31863622
[TBL] [Abstract][Full Text] [Related]
10. Spatial clusters of HIV-1 genotypes in a recently infected population in Yunnan, China.
Chen M; Ma Y; Chen H; Dai J; Luo H; Yang C; Dong L; Jin X; Yang M; Yang L; Song L; Song Z; Jia M
BMC Infect Dis; 2019 Jul; 19(1):669. PubMed ID: 31357947
[TBL] [Abstract][Full Text] [Related]
11. Effects of CD4 Cell Counts and Viral Load Testing on Mortality Rates in Patients With HIV Infection Receiving Antiretroviral Treatment: An Observational Cohort Study in Rural Southwest China.
Shen Z; Zhu Q; Tang Z; Pan SW; Zhang H; Jiang H; Chen Y; Lan G; Xing H; Liao L; Feng Y; Ruan Y; Shao Y
Clin Infect Dis; 2016 Jul; 63(1):108-14. PubMed ID: 27001800
[TBL] [Abstract][Full Text] [Related]
12. No Difference in Prevalence of Transmitted Drug Resistance between Injection Drug Users and Non-Injection Drug Users: A Cross-Sectional Study among Antiretroviral Treatment-Naïve HIV Patients.
Chen R; Liang B; Wen B; Huang G; Ning C; Lao C; Jiang J; Liu J; Zhou B; Huang J; Chen J; Zang N; Liao Y; Mo D; Ye L; Liang H
Intervirology; 2018; 61(6):281-291. PubMed ID: 31018203
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 molecular epidemiology among newly diagnosed HIV-1 individuals in Hebei, a low HIV prevalence province in China.
Lu X; Kang X; Liu Y; Cui Z; Guo W; Zhao C; Li Y; Chen S; Li J; Zhang Y; Zhao H
PLoS One; 2017; 12(2):e0171481. PubMed ID: 28178737
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study.
Lam EP; Moore CL; Gotuzzo E; Nwizu C; Kamarulzaman A; Chetchotisakd P; van Wyk J; Teppler H; Kumarasamy N; Molina JM; Emery S; Cooper DA; Boyd MA
AIDS Res Hum Retroviruses; 2016 Sep; 32(9):841-50. PubMed ID: 27346600
[TBL] [Abstract][Full Text] [Related]
15. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China.
Wang Z; Zhang M; Zhang R; Liu L; Shen Y; Wang J; Lu H
BMC Infect Dis; 2019 Apr; 19(1):313. PubMed ID: 30961560
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Vpr Genetic Variations between Chinese Major Circulating Recombinants CRF01_AE and CRF07_BC.
Du L; Wang L; Yu T; Xin R; Meng Z
Curr HIV Res; 2020; 18(3):165-171. PubMed ID: 32096745
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the immunological response to antiviral therapy in patients with different subtypes of HIV/AIDS: a retrospective cohort study.
Liu X; Wang Y; Yang Z; Wu Z; Li J; Tong Z; Li X; Ren F; Zhu X; Jin M; Mao G
BMJ Open; 2024 May; 14(5):e072597. PubMed ID: 38749684
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a Novel HIV-1 Recombinant Form (CRF01_AE/CRF07_BC/CRF08_BC) Identified from Guangxi, China.
Liang B; Yang Y; Zhang F; Li K; Yang Y; Ou W; Huang J; Ning C; Ye L; Liang H
AIDS Res Hum Retroviruses; 2020 Feb; 36(2):143-152. PubMed ID: 31482724
[TBL] [Abstract][Full Text] [Related]
19. Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan province of China.
Zhang Y; Lu L; Ba L; Liu L; Yang L; Jia M; Wang H; Fang Q; Shi Y; Yan W; Chang G; Zhang L; Ho DD; Chen Z
PLoS Med; 2006 Nov; 3(11):e443. PubMed ID: 17105339
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 subtype B/B' and baseline drug resistance mutation are associated with virologic failure: a multicenter cohort study in China.
Li Y; Gu L; Han Y; Xie J; Wang H; Lv W; Song X; Li Y; Iwamoto A; Ishida T; Li T;
J Acquir Immune Defic Syndr; 2015 Mar; 68(3):289-97. PubMed ID: 25501612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
